Clinical Trials in Nizhny Novgorod, Russia
29 recruiting
Showing 1–20 of 31 trials
Recruiting
Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
DepressionBipolar I Disorder
AbbVie380 enrolled81 locationsNCT04777357
Recruiting
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
Prostate Cancer
AstraZeneca400 enrolled22 locationsNCT07052578
Recruiting
Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid TumorsHematologic Malignancies
Merck Sharp & Dohme LLC3,500 enrolled782 locationsNCT03486873
Recruiting
Phase 3
A Study of Daratumumab
Multiple Myeloma
Janssen Research & Development, LLC500 enrolled92 locationsNCT05438043
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC700 enrolled175 locationsNCT01804686
Recruiting
TReatment Approaches and bIomarkers preValence in bladdEr Cancer in RuSsian Federation
Bladder Cancer
AstraZeneca600 enrolled22 locationsNCT07038928
Recruiting
Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia
Neurofibromatosis
AstraZeneca200 enrolled13 locationsNCT07088991
Recruiting
Lysosomal Acid Lipase Deficiency in Risk Groups
Lysosomal Acid Lipase Deficiency
AstraZeneca1,200 enrolled4 locationsNCT07455864
Recruiting
Not Applicable
REsults of LOw Anterior Resections With or Without Preventive Stoma in Nonemergency Department
Rectal Cancer SurgeryTMEMiddle Rectal Cancer+2 more
ANO Scientific and Practical Club for the Development of Modern Medical Technologies442 enrolled7 locationsNCT07463261
Recruiting
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)
Severe Asthma
AstraZeneca5,000 enrolled37 locationsNCT06472310
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Fabry Disease
Genzyme, a Sanofi Company9,000 enrolled283 locationsNCT00196742
Recruiting
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry Study
Uncontrolled Asthma
AstraZeneca9,000 enrolled47 locationsNCT06521229
Recruiting
Phase 3
The Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients
RhinosinusitisRhinosinusitis Acute
Materia Medica Holding552 enrolled44 locationsNCT06901297
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
Lysosomal Acid Lipase DeficiencyWolman DiseaseCholesterol Ester Storage Disease+4 more
Alexion Pharmaceuticals, Inc.300 enrolled104 locationsNCT01633489
Recruiting
CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
AstraZeneca2,000 enrolled41 locationsNCT05887011
Recruiting
Phase 3
A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis
Relapsing-remitting Multiple Sclerosis (RRMS)
Biocad292 enrolled1 locationNCT07321093
Recruiting
Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation
Prostate Cancer
AstraZeneca400 enrolled17 locationsNCT07146113
Recruiting
Phase 3
Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia
Alzheimer Type Dementia
Bigespas LTD450 enrolled12 locationsNCT07251023
Recruiting
Phase 3
Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism
Pulmonary Embolism
Supergene, LLC486 enrolled24 locationsNCT06362746
Recruiting
Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation
Hidradenitis Suppurativa
Novartis Pharmaceuticals300 enrolled20 locationsNCT06517732